Report #2830590

Received Mar 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 43 yrs
State: IL
Recovered: Unknown
Vaccinated: Oct 2, 2024
Onset: Oct 2, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	4ZN3H	IM

Symptoms (1)

Underdose

Symptom narrative

pediatric immunizaton was given to an adult; pediatric immunizaton was given to an adult; This non-serious case was reported by a other health professional and described the occurrence of underdose in a 43-year-old male patient who received HBV (Engerix B pediatric) (batch number 4ZN3H, expiry date 01-DEC-2026) for prophylaxis. On 02-OCT-2024, the patient received Engerix B pediatric (intramuscular) 1 ml. On 02-OCT-2024, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: pediatric immunizaton was given to an adult) and adult use of a child product (Verbatim: pediatric immunizaton was given to an adult). The outcome of the underdose and adult use of a child product were unknown. Additional Information: GSK Receipt Date: 13-NOV-2024 The other health professional reported that the pediatric immunization was given to an adult which led to underdose and adult use of a child product.